Patient Perspectives on the Value of Stereotactic Body Radiotherapy in the Management of Breast Cancer: The PERSPECTIVE Study
While extension of life was the primary desired treatment outcome of SBRT for oligometastatic breast cancer , all participants were willing to consider SBRT for its minimal side effects and potential benefits in local control and durable pain control, even in the absence of a survival benefit.
Authors
- Anna M. Kirby (ORCID: https://orcid.org/0000-0002-5528-1669)
- Gill Ross
- Susanne Cruickshank (ORCID: https://orcid.org/0000-0003-0204-4739)
- S. K. Nagpal
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
Publication Details
- Journal
- Clinical Oncology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.clon.2024.103738
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.29